Mindwalk Holdings Corp. cash flow statement
In fiscal 2026, Mindwalk Holdings Corp.'s operations generated −$9.0m of cash; it spent $288,483 on capital projects, leaving free cash flow of −$9.3m.
Cash flow statement
| Fiscal year | 2020Apr 2020 | 2021Apr 2021 | 2022Apr 2022 | 2023Apr 2023 | 2024Apr 2024 | 2025Apr 2025 | 2026Apr 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | −1 | −0 | −8 | −15 | −2 | −5 | −9 |
| Depreciation and amortisation | 2 | 2 | 2 | — | — | — | — |
| Stock-based pay | 1 | 2 | 2 | 1 | 1 | 0 | 1 |
| Capital spending | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Free cash flow | −1 | −2 | −9 | −16 | −3 | −5 | −9 |
| Free cash flow after stock pay | −2 | −4 | −11 | −18 | −5 | −5 | −10 |
Compare with peers
- Surrozen, Inc. cash flow
- Relay Therapeutics, Inc. cash flow
- Caribou Biosciences, Inc. cash flow
- Opus Genetics, Inc. cash flow
- Lineage Cell Therapeutics, Inc. cash flow
Head to head: HYFT vs SRZNHYFT vs RLAYCRBU vs HYFTHYFT vs IRD
More: Biotechnology stocks compared, Health Care sector, rankings of US companies